Building the digital ecosystem required for tomorrow's clinical trials
Date: 9th October
Speaker: Jaquie Finn
Underlying stress conditions, from occasional acute stress through to diagnosable chronic conditions, can have a profound affect on clinical trials. It's vital that pharmaceutical companies fully understand individual participant's baseline stress levels in order to assess drug action and efficacy during trials. Cambridge Consultants is investigating the measured inputs that will allow us to build an effective, AI-driven stress monitoring system. Jaquie Finn will present the work to date and map out the ultimate vision: a full digital ecosystem for managing clinical trials.
Jaquie is Head of Digital Health at Cambridge Consultants and leads the initiative to provide strategic guidance and practical support for clients transitioning their business model to include a digital element. These digital elements include device connectivity, data science, launch strategies, behavioural science and digital service design.
Jaquie has a BSc in Applied Biology, 10 years’ experience in Molecular Biology and 15 years’ experience of Product Management and Marketing for software, hardware and digital services in medical and life science industries that include immunology, ophthalmology, neuroscience and bioinformatics. Jaquie has also worked in telecommunications, food hygiene and intelligence informatics.
Jaquie is a member of the Chartered Institute of Marketing (CIM).